Results 211 to 220 of about 554,589 (315)

Super-stereotypy II: Enhancement of a complex movement sequence by intraventricular dopamine D1 agonists [PDF]

, 2000
Kent Berridge, J. Wayne Aldridge
openalex   +1 more source

Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas. [PDF]

Endocr Oncol
Mignone E, Jukes AK, Valentine R, Allison R, De Sousa SMC.   +4 more
europepmc   +1 more source

The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. [PDF]

BMC Endocr Disord, 2021
Wang S, Wang A, Zhang Y, Zhu K, Wang X, Chen Y, Wu J.   +6 more
europepmc   +1 more source

GABA in the Deep Layers of the Superior Colliculus/Mesencephalic Reticular Formation Mediates the Enhancement of Startle by the Dopamine D₁Receptor Agonist SKF 82958 in Rats [PDF]

, 2000
Edward G. Meloni, Michael J. Davis
openalex   +1 more source

Genetic and Pharmacological Inhibition of Metabotropic Glutamate Receptor Signalling Extends Lifespan in Drosophila

Aging Cell, EarlyView.
We show that genetic and pharmacological inhibition of the metabotropic glutamate receptor, DmGluRA extends Drosophila lifespan, improves stress tolerance and alters early‐life locomotion. Several markers indicative of reduced ribosomal biogenesis, a hallmark of longevity, were also detected in these flies.
Cui Guan, Abigail Otchere, Mihails Laskovs, Irene Papatheodorou, Cathy Slack   +4 more
wiley   +1 more source

Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease. [PDF]

J Neurol
Staubo SC, Fuskevåg OM, Toft M, Lie IH, Alvik KMJ, Jostad P, Tingvoll SH, Lilleng H, Rosqvist K, Størset E, Odin P, Dietrichs E, Dietrichs ES.   +12 more
europepmc   +1 more source

Prolactin-Secreting Leiomyoma Causing Hyperprolactinaemia Unresponsive to Dopamine Agonist Therapy and Resolution following Myomectomy. [PDF]

Case Rep Endocrinol, 2021
Barry L, Pather S, Gargya A, Marren A.
europepmc   +1 more source

Enhanced Microglial Engulfment of Dopaminergic Synapses Induces Parkinson's Disease‐Related Executive Dysfunction in an Acute LPC Infusion Targeting the mPFC

Aging Cell, EarlyView.
Parkinson's disease with executive dysfunction is a challenge. Our study reveals a novel pathway where abnormally elevated LPC induces miR‐2885/TDP‐43 signal activation in microglia, leading to dopaminergic terminal phagocytosis, and suggests that supplementing dopamine or inhibiting related microglial activation can mitigate the dysfunction, providing
Yehao Liu, Rui Chen, Chunyan Mu, Junjie Diao, Yurong Guo, Xiaoyu Yao, Shijie Shi, Mengying Wang, Zhi Zhang, Xiaoling Qin, Chuanxi Tang   +10 more
wiley   +1 more source

Sex-based disparities in dopamine agonist response in patients with restless legs syndrome. [PDF]

J Sleep Res
Mogavero MP, Antelmi E, Lanza G, Marelli S, Castelnuovo A, Tinazzi M, DelRosso LM, Silvestri R, Ferri R, Ferini Strambi L.   +9 more
europepmc   +1 more source

Blood phosphatidylethanol measurements indicate GLP‐1 receptor stimulation causes delayed decreases in alcohol consumption

Alcohol, Clinical and Experimental Research, EarlyView.
Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) are effective for treating obesity (BMI ≥30) and are being investigated as a novel treatment for alcohol use disorder (AUD). This secondary analysis of a randomized clinical trial evaluated the effect of exenatide versus placebo on alcohol consumption using phosphatidylethanol (PEth) in 30 AUD ...
Mathias E. Jensen, Mette K. Klausen, Marianne L. Bergmann, Gitte M. Knudsen, Tina Vilsbøll, Christophe Stove, Anders Fink‐Jensen   +6 more
wiley   +1 more source